rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Barbara W. Bodem

Director

Company insider

Files Form 4 as: Director, BioMarin Pharmaceutical; Director, Option Care Health; Director, Enovis; Director, Syneos Health; Director, Turning Point Therapeutics; SVP, Chief Financial Officer, Hill-Rom Holdings; Director, Invacare.

In numbers

Trades disclosed
75
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
7
Companies where not an officer
6
First trade
18 Aug 2017
Last trade
2 Jun 2026
Last filed
4 Jun 2026

Companies traded

Where they are an officer
Hill-Rom HoldingsOfficer · last 13 Dec 20210 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
BMRN BioMarin PharmaceuticalDirector · Biotechnology · last 2 Jun 20260 buys · 0 sells
OPCH Option Care HealthDirector · Providers & Facilities · last 20 May 20260 buys · 0 sells
ENOV EnovisDirector · Medical Devices · last 19 May 20260 buys · 0 sells
Syneos HealthDirector · last 28 Sep 20230 buys · 0 sells
Turning Point TherapeuticsDirector · last 17 Aug 20220 buys · 0 sells
InvacareDirector · last 16 Mar 20180 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
2 Jun 2026filed 4 Jun 2026BMRN BioMarin PharmaceuticalBiotechnologySEC FORM 4 Code A—7,490 at $0.00filing
2 Jun 2026filed 4 Jun 2026BMRN BioMarin PharmaceuticalBiotechnologySEC FORM 4 Code A—7,490 at $0.00filing
20 May 2026filed 22 May 2026OPCH Option Care HealthProviders & FacilitiesSEC FORM 4 Code A—8,997 at $0.00filing
20 May 2026filed 22 May 2026OPCH Option Care HealthProviders & FacilitiesSEC FORM 4 Code A—8,997 at $0.00filing
19 May 2026filed 21 May 2026ENOV EnovisMedical DevicesSEC FORM 4 Code A—9,346 at $0.00filing
19 May 2026filed 21 May 2026ENOV EnovisMedical DevicesSEC FORM 4 Code A—9,346 at $0.00filing
21 May 2025filed 23 May 2025ENOV EnovisMedical DevicesSEC FORM 4 Code A—6,598 at $0.00filing
20 May 2025filed 22 May 2025BMRN BioMarin PharmaceuticalBiotechnologySEC FORM 4 Code A—6,650 at $0.00filing
14 May 2025filed 19 May 2025OPCH Option Care HealthProviders & FacilitiesSEC FORM 4 Code A—5,034 at $0.00filing
21 May 2024filed 23 May 2024BMRN BioMarin PharmaceuticalBiotechnologySEC FORM 4 Code A—4,720 at $0.00filing
20 May 2024filed 22 May 2024ENOV EnovisMedical DevicesSEC FORM 4 Code A—4,338 at $0.00filing
15 May 2024filed 17 May 2024OPCH Option Care HealthProviders & FacilitiesSEC FORM 4 Code A—5,325 at $0.00filing
1 Apr 2024filed 3 Apr 2024OPCH Option Care HealthProviders & FacilitiesSEC FORM 4 Code A—1,731 at $0.00filing
27 Dec 2023filed 28 Dec 2023BMRN BioMarin PharmaceuticalBiotechnologySEC FORM 4 Code A—2,180 at $0.00filing
28 Sep 2023filed 28 Sep 2023Syneos HealthSEC FORM 4 Code D$151K3,522 at $43.00filing
28 Sep 2023filed 28 Sep 2023Syneos HealthSEC FORM 4 Code D—4,863 at $0.00filing
25 May 2023filed 30 May 2023Syneos HealthSEC FORM 4 Code A—4,863 at $0.00filing
16 May 2023filed 18 May 2023ENOV Enovisoption or derivative · Medical DevicesSEC FORM 4 Code A—4,167 at $0.00filing
16 May 2023filed 18 May 2023ENOV EnovisMedical DevicesSEC FORM 4 Code A—1,875 at $0.00filing
17 Aug 2022filed 17 Aug 2022Turning Point Therapeuticsoption or derivativeSEC FORM 4 Code D—14,995filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Nobody else traded the same names lately.